셀트리온

068270KOSPIView the 제약 sectorTheme Bio & healthcare

197,600KRWMarket close of 10/21 (Wed)

Up +0.10%+200KRWMarket close of 10/21 (Wed)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/22 (Thu)194,300KRWDown -1.67%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
200,000
High
203,500
Low
196,800
Day range
Day range low 196,800 high 203,500, open 200,000, close 197,600, previous close 197,400
Volume
60×10K shares
119.2B KRW 1.38× the 20-session average

Market close of 10/21 (Wed)

Where it sits in the 1-year range

1-year close range 159,400 to 248,500 won, 43% up from the low

43% of the way up from the lowest close in 1 year (252 sessions) · -20.5% from the high

Usual range

Nothing unusual in the 6 checked items

Free · no sign-inSource from 2021-05-17

Points to check

  • Daily moveusual range+0.10%+0.10%, 0.1× the usual (20-session average ±1.26%)
    That day +0.10% · usual ±1.26% · large-move threshold ±3.0%
  • Trading valueusual range1.4×119.2B KRW, 1.4× the 20-session average
    1.38× the 20-session average · check threshold 3×
  • Earningsusual range1.55 trillion KRWOperating income over the last four quarters 1.55 trillion KRWOperating income, 8 quarters

The other 3 are within the usual range

  • Recent filings0Last 14 days
  • Foreign & institutional+260.1B KRWusual range
  • Data date10/21 (Wed)Market close
See the full check report

Same sector · 제약

Up +0.83%

· 57 of 168 stocks up, preferred shares excluded · trading value 730.8B KRW

Same sector · top by trading value
Stock20DChangeTrading value
삼성바이오로직스Close over the last 20 sessions +1.5%Up +1.87%166.1B KRW
지투지바이오Close over the last 20 sessions +27.6%Up +13.78%49.8B KRW
삼익제약Close over the last 20 sessions -20.3%Up +2.58%47.2B KRW
유한양행Close over the last 20 sessions +11.7%Up +0.46%35.3B KRW
한미약품Close over the last 20 sessions -26.3%Up +0.26%28.1B KRW

Schedule

  • Q3 report due · 11/16 (Mon) · in 24 days
  • Next data 10/23 (Fri) after 08:50

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.